BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 7, 1999
View Archived Issues
Genset strengthens obesity/metabolic disorder program
Read More
Alexion and Harvard utilize xenotransplantation for Alzheimer's disease
Read More
Company Profile: Selective Genetics
Read More
Novartis: Operational Review 1998
Read More
Company Profile: Eos Biotechnology
Read More
Geron acquires Roslin Bio-Med, collaborates with the Roslin Institute
Read More
NCI funds phase II trials of Sugen's lead angiogenesis inhibitor
Read More
Bigmar and Graminex sign licensing agreement for prostatitis therapy
Read More
Protein Design Labs licenses anti-L-selectin antibody to BioNet
Read More
CeNeS in-licenses sipatrigine; company pipeline in review
Read More
Clinical trials of SuperGen's RFS-2000 expanded to Europe
Read More
Novel naturally occurring proteasome inhibitor TMC-95A discovered at Tanabe Seiyaku
Read More
Second-generation SERM advances through the Lilly pipeline
Read More
Spotlight on treatment of hirsutism
Read More
Kissei develops new anticoagulants acting selectively against factor Xa
Read More
BE-55051: novel antitumor substance produced by Streptomyces
Read More
Substituted morpholines as tachykinin antagonists, 5-HT agonists
Read More
Clarion discloses new wound-healing agents in development
Read More
New prostaglandin F analogues from P&G targeted for bone disorders, glaucoma
Read More
Novel strategy for limiting restenosis targets Gbetagamma signaling
Read More
Caspase inhibitor provides neuroprotection in rabbit model of bacterial meningitis
Read More
Diatide: Q1 1999 highlights
Read More
U.K. regulatory filing for Wyeth Lederle Vaccines' meningococcal C conjugate vaccine
Read More
Licensing opportunity from LG Chemical: irreversible HIV protease inhibitor
Read More
PDE4 inhibitor XT-44 inhibits bone loss in animal models of osteopenia
Read More
La Jolla Pharmaceutical: Q1 1999 highlights
Read More
M-5011 compares favorably to indomethacin in model of gouty arthritis
Read More
Celgene: Q1 1999 highlights
Read More
Phase I trial with Ariad's first Dimerizer Drug successfully completed
Read More